FDA clears first digital treatment for depression, but experts caution that research is still early

DX'd - Other
1
2 Likes
2

Sorry didn’t read the article

What exactly is it?

3

Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, is a smartphone app intended for use alongside antidepressant medications for people 22 and older who have a diagnosis of major depressive disorder. It employs a six-week program that combines a new approach called cognitive-emotional training and cognitive behavioral therapy lessons, according to a news release.

1 Like
4

Very cool I wonder if it’s available here. I’ll have to look it up. Thanks for sharing dude.

1 Like